1. Home
  2. NVVE vs GCTK Comparison

NVVE vs GCTK Comparison

Compare NVVE & GCTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nuvve Holding Corp.

NVVE

Nuvve Holding Corp.

HOLD

Current Price

$0.83

Market Cap

1.9M

Sector

Energy

ML Signal

HOLD

Logo GlucoTrack Inc.

GCTK

GlucoTrack Inc.

HOLD

Current Price

$1.16

Market Cap

1.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NVVE
GCTK
Founded
1996
2001
Country
United States
United States
Employees
12
N/A
Industry
Oil Refining/Marketing
Medical/Dental Instruments
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.9M
1.6M
IPO Year
N/A
2011

Fundamental Metrics

Financial Performance
Metric
NVVE
GCTK
Price
$0.83
$1.16
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
258.2K
37.5K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
17910.53
EPS
N/A
30.09
Revenue
N/A
$589,462.00
Revenue This Year
$892.33
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$0.04
Revenue Growth
N/A
N/A
52 Week Low
$0.10
$0.09
52 Week High
$5.69
$15.90

Technical Indicators

Market Signals
Indicator
NVVE
GCTK
Relative Strength Index (RSI) 36.51 24.82
Support Level $0.83 $0.09
Resistance Level $1.13 $4.24
Average True Range (ATR) 0.12 0.11
MACD 0.02 0.05
Stochastic Oscillator 8.00 24.07

Price Performance

Historical Comparison
NVVE
GCTK

About NVVE Nuvve Holding Corp.

Nuvve Holding Corp is accelerating the electrification of transportation through its proprietary vehicle-to-grid (V2G) technology. It helps to support the integration of renewable energy sources, including solar and wind. Its Grid Integrated Vehicle (GIV) platform is refueling the next generation of electric vehicle fleets through bidirectional charging solutions. It has a geographic presence in the United States, the United Kingdom, and Denmark, of which it generates the majority of its revenue in the United States.

About GCTK GlucoTrack Inc.

GlucoTrack Inc is a medical device company. It is focused on defining novel approaches that make diabetes management more accurate and convenient for daily living. The company has developed the GlucoTrack model that measures real-time blood glucose levels. The Company is developing an long-term implantable continuous blood glucose monitoring (CBGM) system, built on healthcare technologies. It is designed to meet the critical needs of insulin-dependent individuals or those at risk of hypoglycemia in the U.S.

Share on Social Networks: